Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Metabolomics-based study of Shensu Ⅱ intervention in mouse with adriamycin-induced nephropathy
Hits 557  Download times 387  Received:December 20, 2022  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2023.03.14
Key Words   Shensu Ⅱ|metabolomics|kidney injury|biomarker
Author NameAffiliationE-mail
DOU Yitian First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinica Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
WANG Yuming School of Pharmacy, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China wangyuming226@163.com 
QU Jingtian First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinica Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
LI Xue School of Pharmacy, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
LI Chong First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinica Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
HAN Yanyan First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinica Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
SHANG Yichun School of Traditional Chinese Medicine, Tianjin University of Chinese Medicine, Tianjin 301617, China  
LIU Chunliu Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
Abstract
    [Objective] To study the protective effect of ShensuⅡintervention on adriamycin-induced nephropathy in mice and its effect on plasma metabolism,and to preliminarily explore the metabolic pathways and possible mechanisms of its intervention.[Methods] A mouse nephropathy model was established by tail vein injection of adriamycin,and the morphological changes of kidney pathology were observed in each group after continuous administration for 14 d. The UPLC-Q-TOF/MS technique was applied to metabolomic study of plasma to screen and identify biomarkers associated with kidney injury and enrich the metabolic pathways to explore the possible mechanism of action of ShensuⅡ.[Results] ShensuⅡsignificantly improved the histopathological changes in the kidney of mice with nephropathy caused by adriamycin injection. The 14 potential biomarkers were screened by metabolomic analysis,involving amino acid metabolism,bile acid metabolism,lipid metabolism,fatty acid metabolism and purine metabolism and other metabolic pathways.[Conclusion] ShensuⅡcan effectively ameliorate the damage in adriamycin nephropathy mice,probably by affecting amino acid metabolism,bile acid metabolism and purine metabolism pathways.

You are the 2311650 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.